DAM
Deltec Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,000
| Closed | -$47.5K | – | 180 |
|
|
2024
Q4 | $47.5K | Hold |
14,000
| – | – | 0.01% | 157 |
|
|
2024
Q3 | $39.9K | Hold |
14,000
| – | – | 0.01% | 151 |
|
|
2024
Q2 | $31.5K | Sell |
14,000
-38,000
| -73% | -$85.5K | 0.01% | 152 |
|
|
2024
Q1 | $115K | Sell |
52,000
-207,246
| -80% | -$458K | 0.02% | 146 |
|
|
2023
Q4 | $609K | Sell |
259,246
-56,000
| -18% | -$132K | 0.14% | 107 |
|
|
2023
Q3 | $586K | Sell |
315,246
-90,944
| -22% | -$169K | 0.13% | 106 |
|
|
2023
Q2 | $1.06M | Sell |
406,190
-215,882
| -35% | -$566K | 0.23% | 85 |
|
|
2023
Q1 | $1.01M | Buy |
622,072
+253,146
| +69% | +$413K | 0.25% | 89 |
|
|
2022
Q4 | $491K | Sell |
368,926
-169,000
| -31% | -$225K | 0.14% | 116 |
|
|
2022
Q3 | $839K | Buy |
537,926
+131,926
| +32% | +$206K | 0.21% | 95 |
|
|
2022
Q2 | $625K | Buy |
406,000
+158,000
| +64% | +$243K | 0.15% | 119 |
|
|
2022
Q1 | $635K | Sell |
248,000
-163,000
| -40% | -$417K | 0.11% | 133 |
|
|
2021
Q4 | $1.2M | Sell |
411,000
-49,500
| -11% | -$145K | 0.2% | 74 |
|
|
2021
Q3 | $1.13M | Buy |
460,500
+185,000
| +67% | +$453K | 0.17% | 90 |
|
|
2021
Q2 | $1.12M | Sell |
275,500
-315,588
| -53% | -$1.28M | 0.15% | 96 |
|
|
2021
Q1 | $2.67M | Sell |
591,088
-102,782
| -15% | -$464K | 0.4% | 55 |
|
|
2020
Q4 | $3.41M | Sell |
693,870
-159,262
| -19% | -$784K | 0.52% | 47 |
|
|
2020
Q3 | $5.06M | Buy |
853,132
+596,000
| +232% | +$3.53M | 0.9% | 28 |
|
|
2020
Q2 | $684K | Buy |
+257,132
| New | +$684K | 0.14% | 126 |
|